Search

Your search keyword '"Brodskyn C"' showing total 95 results

Search Constraints

Start Over You searched for: Author "Brodskyn C" Remove constraint Author: "Brodskyn C"
95 results on '"Brodskyn C"'

Search Results

1. Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11

12. IgG subclass responsible for immune clearance in mice infected with Trypanosoma cruzi.

13. Testing of Four Leishmania Vaccine Candidates in a Mouse Model of Infection with Leishmania (Viannia) braziliensis, the Main Causative Agent of Cutaneous Leishmaniasis in the New World

14. Testing of Four LeishmaniaVaccine Candidates in a Mouse Model of Infection with Leishmania(Viannia) braziliensis, the Main Causative Agent of Cutaneous Leishmaniasis in the New World

15. Differences in Gamma Interferon Production In Vitro Predict the Pace of the In Vivo Response to Leishmania amazonensisin Healthy Volunteers

18. Immunomodulation of human monocytes following exposure to Lutzomyia intermedia saliva

19. Balance of IL-10 and Interferon-γ plasma levels in human visceral leishmaniasis: Implications in the pathogenesis

20. Recent advances in the development and clinical application of miRNAs in infectious diseases.

21. Transcriptome Analysis Identifies the Crosstalk between Dendritic and Natural Killer Cells in Human Cutaneous Leishmaniasis.

23. Prediabetes Induces More Severe Acute COVID-19 Associated With IL-6 Production Without Worsening Long-Term Symptoms.

24. Blockade of TLR2 and TLR4 Attenuates Inflammatory Response and Parasite Load in Cutaneous Leishmaniasis.

25. LTB 4 -Driven Inflammation and Increased Expression of ALOX5 / ACE2 During Severe COVID-19 in Individuals With Diabetes.

26. Obtainment of Macrophages from Human Monocytes to Assess Leishmania braziliensis Infection Rate and Innate Host Immune Response.

27. Inflammasome Activation by CD8 + T Cells from Patients with Cutaneous Leishmaniasis Caused by Leishmania braziliensis in the Immunopathogenesis of the Disease.

28. Leukotriene B 4 licenses inflammasome activation to enhance skin host defense.

29. Granzyme B Produced by Natural Killer Cells Enhances Inflammatory Response and Contributes to the Immunopathology of Cutaneous Leishmaniasis.

30. New Role of P. brasiliensis α-Glucan: Differentiation of Non-conventional Dendritic Cells.

31. Molecular Aspects of Dendritic Cell Activation in Leishmaniasis: An Immunobiological View.

32. Plant-feeding phlebotomine sand flies, vectors of leishmaniasis, prefer Cannabis sativa .

33. Integrated Analysis Reveals That miR-193b, miR-671, and TREM-1 Correlate With a Good Response to Treatment of Human Localized Cutaneous Leishmaniasis Caused by Leishmania braziliensis .

35. Degranulating Neutrophils Promote Leukotriene B4 Production by Infected Macrophages To Kill Leishmania amazonensis Parasites.

36. Dendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex Disease.

37. Understanding the mechanisms controlling Leishmania amazonensis infection in vitro: the role of LTB4 derived from human neutrophils.

38. PLGA nanoparticles loaded with KMP-11 stimulate innate immunity and induce the killing of Leishmania.

39. Functional transcriptomics of wild-caught Lutzomyia intermedia salivary glands: identification of a protective salivary protein against Leishmania braziliensis infection.

40. Dual effect of Lutzomyia longipalpis saliva on Leishmania braziliensis infection is mediated by distinct saliva-induced cellular recruitment into BALB/c mice ear.

41. Experimental infection of dogs with Leishmania and saliva as a model to study Canine Visceral Leishmaniasis.

42. The presence of Tregs does not preclude immunity to reinfection with Leishmania braziliensis.

43. New Insights on the Inflammatory Role of Lutzomyia longipalpis Saliva in Leishmaniasis.

44. Vaccination with L. infantum chagasi nucleosomal histones confers protection against new world cutaneous leishmaniasis caused by Leishmania braziliensis.

45. DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasis.

46. Lutzomyia longipalpis saliva drives apoptosis and enhances parasite burden in neutrophils.

47. Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia.

48. Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis.

49. Neutrophils and macrophages cooperate in host resistance against Leishmania braziliensis infection.

50. Leishmania (Viannia) braziliensis transfectants overexpressing the miniexon gene lose virulence in vivo.

Catalog

Books, media, physical & digital resources